90559876

Information

• Trademark
• 90559876

• Source

• Serial Number

  90559876

• International Classifications

  • 35 - Advertising
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  March 04, 2021
  3 years ago

• Transaction Date

  April 30, 2024
  9 months ago

• Status Date

  April 30, 2024
  9 months ago

• Location Date

  April 30, 2024
  9 months ago

• Status Code

  602

• Current Location

  TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  STOIDES, KATHERINE

• Attorney Name

  Gary P. Oakeson

  Law Office Assigned Location Code

  L10

• Owners

  • NUVO PHARMACEUTICALS (IRELAND) LIMITED

Case File Statements

• GS0401: Custom manufacturing of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; custom manufacturing of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations
• DM0000: The mark consists of three geometric shapes including two differently sized inward-facing triangles and one trapezoid positioned at an angle between the two triangles.
• GS0351: Operation of a commercial health care business, namely, developing marketing strategies all in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; operation of a commercial health care business, namely, developing of marketing strategies all in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of pharmaceuticals and drugs, namely, developing marketing strategies all in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of health care products, namely, developing marketing strategies all in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; Operation of a commercial health care business, namely, distributorship services in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; operation of a commercial health care business, namely, distributorship services in the field of non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of pharmaceuticals and drugs, namely, distributorship services in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of health care products, namely, distributorship services in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations
• GS0451: Licensing of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; Licensing of health care products, namely, non-medicated and non-prescription products used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations
• GS0421: Research, development and design of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; research, development and design of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations

Case File Event Statements

• 9/27/2021 - 3 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/8/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/3/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/4/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 9/27/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 9/27/2021 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/27/2021 - 3 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/28/2022 - 2 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/28/2022 - 2 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/30/2022 - 2 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/4/2022 - 2 years ago

  11 - ASSIGNED TO EXAMINER Type: DOCK

• 5/3/2022 - 2 years ago

  12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/3/2022 - 2 years ago

  13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/3/2022 - 2 years ago

  14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/3/2022 - 2 years ago

  15 - ASSIGNED TO LIE Type: ALIE

• 5/3/2022 - 2 years ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/27/2022 - 2 years ago

  17 - SUSPENSION LETTER WRITTEN Type: CNSL

• 5/27/2022 - 2 years ago

  18 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 5/27/2022 - 2 years ago

  19 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 12/7/2022 - 2 years ago

  20 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 12/7/2022 - 2 years ago

  21 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 12/7/2022 - 2 years ago

  22 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 3/3/2023 - a year ago

  23 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 3/6/2023 - a year ago

  24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/6/2023 - a year ago

  25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/24/2023 - a year ago

  26 - SUSPENSION LETTER WRITTEN Type: CNSL

• 3/24/2023 - a year ago

  27 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 3/24/2023 - a year ago

  28 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 12/14/2023 - a year ago

  29 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 1/6/2024 - a year ago

  30 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 1/6/2024 - a year ago

  31 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 1/6/2024 - a year ago

  32 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 4/30/2024 - 9 months ago

  34 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 4/30/2024 - 9 months ago

  33 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2